Insider · CIK 0002062722
Julie Fazio
Files at UGI (UGI CORP /PA/). First filing -, latest -.
In brief
Julie Fazio files SEC Form 4 as president at UGI (UGI CORP /PA/). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Julie Fazio has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 11, 2026 | UGI UGI CORP /PA/ | MOption exercise UGI Common Stock | +1,350 | $0.00 | $0 | 1,350 | Jan 13, 2026 |
| Jan 11, 2026 | UGI UGI CORP /PA/ | FTax withholding UGI Common Stock | -805 | $37.07 | $30k | 545 | Jan 13, 2026 |
| Jan 11, 2026 | UGI UGI CORP /PA/ | MOption exercise Stock Unitsderivative | -1,350 | $0.00 | $0 | 0 | Jan 13, 2026 |
| Jan 1, 2026 | UGI UGI CORP /PA/ | AGrant or award Performance Unitsderivative | +4,824 | $0.00 | $0 | 4,824 | Jan 5, 2026 |
| Jan 1, 2026 | UGI UGI CORP /PA/ | AGrant or award Stock Unitsderivative | +3,206 | $0.00 | $0 | 3,206 | Jan 5, 2026 |
Questions about Julie Fazio
Answered from the filings on this page, as of the latest one.
Is Julie Fazio buying or selling?
Julie Fazio has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Julie Fazio's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Julie Fazio has 0.
Where does Julie Fazio file Form 4?
Julie Fazio has filed Form 4 at UGI (UGI CORP /PA/) as President of Subsidiary. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.